Your browser doesn't support javascript.
Redox imbalance in COVID-19 pathophysiology.
Majumder, Nairrita; Deepak, Vishal; Hadique, Sarah; Aesoph, Drake; Velayutham, Murugesan; Ye, Qing; Mazumder, Md Habibul Hasan; Lewis, Sara E; Kodali, Vamsi; Roohollahi, Anthony; Guo, Nancy Lan; Hu, Gangqing; Khramtsov, Valery V; Johnson, Richard J; Wen, Sijin; Kelley, Eric E; Hussain, Salik.
  • Majumder N; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Deepak V; Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Hadique S; Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Aesoph D; WVU Cancer Institute, West Virginia University, Morgantown, WV, USA; Lane Department of Computer Science & Electrical Engineering, West Virginia University, Morgantown, WV, USA.
  • Velayutham M; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA; Department of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Ye Q; WVU Cancer Institute, West Virginia University, Morgantown, WV, USA; Lane Department of Computer Science & Electrical Engineering, West Virginia University, Morgantown, WV, USA.
  • Mazumder MHH; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Lewis SE; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Kodali V; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Roohollahi A; Department of Internal Medicine, Section of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Guo NL; WVU Cancer Institute, West Virginia University, Morgantown, WV, USA; Department of Occupational and Environmental Health Sciences, School of Public Health, West Virginia University, Morgantown, WV, USA.
  • Hu G; WVU Cancer Institute, West Virginia University, Morgantown, WV, USA; Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV, USA.
  • Khramtsov VV; Department of Biochemistry and Molecular Medicine, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Johnson RJ; Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Wen S; Department of Epidemiology and Biostatistics, West Virginia University, Morgantown, WV, USA.
  • Kelley EE; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.
  • Hussain S; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA; Department of Microbiology, Immunology & Cell Biology, West Virginia University, Morgantown, WV, USA. Electronic address: salik.hussain@hsc.wvu.edu.
Redox Biol ; 56: 102465, 2022 10.
Article in English | MEDLINE | ID: covidwho-2105815
ABSTRACT

BACKGROUND:

The pathophysiologic significance of redox imbalance is unquestionable as numerous reports and topic reviews indicate alterations in redox parameters during corona virus disease 2019 (COVID-19). However, a more comprehensive understanding of redox-related parameters in the context of COVID-19-mediated inflammation and pathophysiology is required.

METHODS:

COVID-19 subjects (n = 64) and control subjects (n = 19) were enrolled, and blood was drawn within 72 h of diagnosis. Serum multiplex assays and peripheral blood mRNA sequencing was performed. Oxidant/free radical (electron paramagnetic resonance (EPR) spectroscopy, nitrite-nitrate assay) and antioxidant (ferrous reducing ability of serum assay and high-performance liquid chromatography) were performed. Multivariate analyses were performed to evaluate potential of indicated parameters to predict clinical outcome.

RESULTS:

Significantly greater levels of multiple inflammatory and vascular markers were quantified in the subjects admitted to the ICU compared to non-ICU subjects. Gene set enrichment analyses indicated significant enhancement of oxidant related pathways and biochemical assays confirmed a significant increase in free radical production and uric acid reduction in COVID-19 subjects. Multivariate analyses confirmed a positive association between serum levels of VCAM-1, ICAM-1 and a negative association between the abundance of one electron oxidants (detected by ascorbate radical formation) and mortality in COVID subjects while IL-17c and TSLP levels predicted need for intensive care in COVID-19 subjects.

CONCLUSION:

Herein we demonstrate a significant redox imbalance during COVID-19 infection affirming the potential for manipulation of oxidative stress pathways as a new therapeutic strategy COVID-19. However, further work is requisite for detailed identification of oxidants (O2•-, H2O2 and/or circulating transition metals such as Fe or Cu) contributing to this imbalance to avoid the repetition of failures using non-specific antioxidant supplementation.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Redox Biol Year: 2022 Document Type: Article Affiliation country: J.redox.2022.102465

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Redox Biol Year: 2022 Document Type: Article Affiliation country: J.redox.2022.102465